NRC HEALTH
NRC HEALTH
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 3 | 4 | 2 | 5 | 3 | 4 | 3 | 0 | 2 | 7 | 4 | 22 | |||||
Accounts Receivable Net Current | 11 | 11 | 13 | 12 | 11 | 11 | 11 | 10 | 11 | 12 | 14 | 12 | |||||
Prepaid Expense Current | 6 | 4 | 4 | 5 | 6 | 3 | 5 | 5 | 6 | 4 | 6 | 6 | |||||
Income Taxes Receivable | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||||
Other Assets Current | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | |||||
Assets Current | 20 | 20 | 20 | 25 | 20 | 20 | 21 | 17 | 20 | 24 | 25 | 41 | |||||
Property Plant And Equipment And Finance Lease Rig… | 40 | 40 | 41 | 42 | 40 | 38 | 36 | 34 | 32 | 28 | 26 | 23 | |||||
Intangible Assets Net Excluding Goodwill | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 1 | 1 | 1 | 2 | 2 | |||||
Goodwill | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 62 | 62 | 62 | 62 | 62 | |||||
Capitalized Contract Cost Net Noncurrent | 3 | 2 | 2 | 2 | 2 | 2 | - | 1 | 1 | 1 | 2 | 2 | |||||
Operating Lease Right Of Use Asset | - | 1 | 1 | 1 | 1 | 2 | - | 2 | 2 | 2 | 1 | 0 | |||||
Other Assets Noncurrent | 3 | 3 | 2 | 2 | 3 | 4 | 6 | 2 | 3 | 3 | 4 | 5 | |||||
Deferred Income Tax Assets Net | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | |||||
Assets | 135 | 135 | 136 | 141 | 135 | 133 | 132 | 119 | 121 | 122 | 120 | 134 | |||||
Liabilities Current | |||||||||||||||||
Notes Payable Current | 4 | 4 | 4 | 4 | 3 | 5 | 4 | 8 | 8 | 7 | 5 | 5 | |||||
Lines Of Credit Current | - | - | - | - | 4 | - | 5 | 9 | 7 | - | 5 | - | |||||
Accounts Payable Current | 2 | 1 | 1 | 1 | 2 | 1 | 3 | 1 | 2 | 1 | 1 | 2 | |||||
Employee Related Liabilities Current | 7 | 7 | 7 | 6 | 5 | 5 | 5 | 4 | 5 | 4 | 5 | 5 | |||||
Accrued Liabilities Current | 3 | 3 | 4 | 6 | 5 | 5 | 6 | 5 | 6 | 5 | 5 | 4 | |||||
Dividends Payable Current | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||||
Contract With Customer Liability Current | 17 | 16 | 18 | 16 | 16 | 16 | 17 | 15 | 15 | 15 | 16 | 15 | |||||
Accrued Income Taxes Current | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | - | - | |||||
Other Liabilities Current | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Business Combination Contingent Consideration Liab… | - | - | - | - | - | 1 | 1 | - | - | 0 | - | - | |||||
Liabilities Current | 38 | 37 | 39 | 36 | 38 | 36 | 44 | 46 | 49 | 36 | 41 | 34 | |||||
Long Term Notes Payable | 74 | 75 | 76 | 77 | 59 | 58 | 45 | 26 | 28 | 29 | 14 | 15 | |||||
Deferred Income Tax Liabilities Net | 6 | 6 | 3 | 4 | 5 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | |||||
Other Liabilities Noncurrent | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 2 | |||||
Liabilities | 121 | 121 | 121 | 120 | 106 | 101 | 97 | 79 | 84 | 73 | 62 | 56 | |||||
Stockholders Equity | |||||||||||||||||
Business Combination Contingent Consideration Liab… | - | - | - | - | - | 0 | 0 | - | - | 0 | - | - | |||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 186 | 184 | 182 | 181 | 181 | 180 | 180 | 180 | 180 | 178 | 177 | 177 | |||||
Retained Earnings Accumulated Deficit | -18 | -17 | -15 | -17 | -14 | -17 | -21 | -24 | -27 | -31 | -36 | -17 | |||||
Treasury Stock Common Value | - | - | - | - | - | - | - | - | - | - | -82 | -82 | |||||
Treasury Stock Value | -154 | -153 | -152 | -143 | -137 | -132 | -125 | -116 | -116 | -99 | - | - | |||||
Stockholders Equity | 13 | 14 | 14 | 21 | 30 | 31 | 35 | 40 | 37 | 49 | 58 | 78 | |||||
Liabilities And Stockholders Equity | 135 | 135 | 136 | 141 | 135 | 133 | 132 | 119 | 121 | 122 | 120 | 134 | |||||
Allowance For Doubtful Accounts Receivable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accumulated Other Comprehensive Income Loss Foreig… | - | - | - | - | - | 0 | - | - | - | 0 | - | - | |||||
Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Preferred Stock Shares Authorized | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 110 | 110 | 110 | 110 | 110 | 110 | 110 | 110 | 110 | 110 | 110 | 110 | |||||
Common Stock Shares Issued | 32 | 32 | 32 | 32 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | |||||
Shares Outstanding | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 24 | 24 | 24 | 25 | 25 | |||||
Treasury Stock Common Shares | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 7 | 7 | 7 | 6 | 6 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 9.35% | 17.43% | - | - | - | - | - | - | - | - | - | - |
| 2025 | 4.00% | 29.29% | 7.73% | -2.72% | -11.15% | -22.11% | 15.58% | 28.03% | 44.56% | 23.13% | 23.85% | 37.15% |
| 2024 | -2.33% | -19.76% | -13.78% | 8.31% | 6.94% | -14.22% | -1.65% | -12.22% | -9.55% | -28.39% | -13.06% | 0.53% |
| 2023 | - | - | - | -0.49% | 11.33% | 1.82% | 2.44% | -2.05% | -0.71% | -2.20% | -16.50% | -23.94% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.52 | 0.55 | 0.53 | 0.70 | 0.54 | 0.55 | 0.47 | 0.37 | 0.41 | 0.67 | 0.61 | 1.21 | |||||
| Quick Ratio | 0.37 | 0.44 | 0.41 | 0.57 | 0.39 | 0.45 | 0.36 | 0.26 | 0.28 | 0.56 | 0.47 | 1.05 | |||||
| Working Capital | -18.49M | -16.41M | -18.17M | -10.61M | -17.37M | -16.26M | -23.58M | -28.78M | -28.84M | -11.84M | -16.06M | 7.25M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 8.97 | 8.64 | 8.48 | 5.63 | 3.56 | 3.24 | 2.81 | 1.96 | 2.27 | 1.50 | 1.08 | 0.72 | |||||
| Interest Coverage TTM | 3.82 | 4.74 | 6.68 | 8.25 | 12.13 | 13.56 | 17.48 | 24.73 | 32.45 | 46.46 | 46.16 | 41.44 | |||||
| Debt Ratio | 0.90 | 0.90 | 0.89 | 0.85 | 0.78 | 0.76 | 0.74 | 0.66 | 0.69 | 0.60 | 0.52 | 0.42 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 1.03 | 1.03 | 1.04 | 1.08 | 1.10 | 1.12 | 1.14 | 1.16 | 1.16 | 1.18 | 1.17 | 1.10 | |||||
| Days Sales Outstanding TTM | 29.17 | 29.44 | 31.24 | 29.23 | 29.00 | 29.89 | 32.32 | 27.38 | 31.38 | 32.97 | 36.62 | 30.73 | |||||
| Receivables Turnover TTM | 12.51 | 12.40 | 11.69 | 12.49 | 12.59 | 12.21 | 11.29 | 13.33 | 11.63 | 11.07 | 9.97 | 11.88 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 0.41 | 0.52 | 0.74 | 0.79 | 1.05 | 1.04 | 1.14 | 1.22 | 1.27 | 1.26 | 1.16 | 1.18 | |||||
| Free Cash Flow Per Share TTM | 0.53 | 0.44 | 0.26 | 0.15 | 0.65 | 0.81 | 1.06 | 0.95 | 1.08 | 0.91 | 0.84 | 0.86 | |||||
| Dividend Per Share TTM | 0.54 | 0.49 | 0.50 | 0.49 | 0.49 | 0.48 | 0.49 | 1.52 | 1.52 | 1.48 | 1.60 | 0.72 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | - | - | - | - | - | - | - | - | 100.83% | 100.58% | 100.59% | 100.68% | |||||
| Operating Profit Margin TTM | 14.11% | 16.44% | 19.78% | 19.78% | 24.79% | 24.60% | 25.88% | 26.86% | 26.99% | 26.95% | 27.28% | 28.11% | |||||
| Net Profit Margin TTM | 6.52% | 8.44% | 11.76% | 12.78% | 17.13% | 17.32% | 18.79% | 20.01% | 20.60% | 20.84% | 19.33% | 19.65% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -1.88% | -3.96% | -3.50% | -4.08% | -4.15% | -3.72% | -3.07% | -1.47% | -1.46% | -1.97% | -1.98% | -2.19% | |||||
| Net Income Growth (1Y) | -62.68% | -53.19% | -39.57% | -38.74% | -20.27% | -19.98% | -5.82% | 0.32% | 0.47% | -2.61% | -17.35% | -19.29% | |||||
| EPS Growth (1Y) | -60.67% | -50.43% | -35.23% | -35.46% | -17.16% | -17.15% | -2.49% | 3.29% | 3.48% | -1.09% | -16.83% | -17.64% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 40.65 | 35.61 | 16.85 | 20.52 | 11.65 | 16.04 | 18.92 | 17.59 | 29.10 | 29.21 | 35.21 | 33.22 | |||||
| P/B TTM | 27.21 | 29.52 | 19.26 | 17.25 | 9.51 | 12.71 | 14.79 | 12.80 | 23.92 | 18.48 | 17.49 | 12.47 | |||||
| P/S TTM | 2.65 | 3.01 | 1.98 | 2.62 | 2.00 | 2.78 | 3.55 | 3.52 | 5.99 | 6.09 | 6.81 | 6.53 | |||||
| Market Cap | 367.26M | 413.05M | 275.69M | 367.84M | 282.04M | 397.63M | 512.23M | 514.72M | 883.62M | 904.61M | 1.01B | 969.31M | |||||
| Enterprise Value | 442.75M | 487.95M | 353.51M | 443.52M | 344.74M | 456.08M | 562.40M | 556.46M | 923.99M | 934.64M | 1.03B | 966.78M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 11.46M | 9.77M | 5.65M | 3.30M | 14.94M | 19.18M | 25.18M | 22.70M | 25.68M | 22.33M | 20.53M | 21.25M | |||||
| Net Debt | 75.49M | 74.90M | 77.82M | 75.68M | 62.70M | 58.45M | 50.17M | 41.74M | 40.37M | 30.03M | 20.00M | -2.53M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
NRC HEALTH (NRC) — SEC Financial Statements & Analysis
NRC HEALTH (NRC) is a services-commercial physical & biological research company, incorporated in DE. NRC HEALTH trades on NRC: Nasdaq as: NRC. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), NRC HEALTH reported a -1.88% year-over-year revenue growth, a Gross Profit Margin of 100.83% (TTM), a Debt-to-Equity ratio of 8.97x, a Price-to-Sales (P/S) ratio of 2.65x (TTM), a Price-to-Book (P/B) ratio of 27.21 (TTM), at a market cap of $367.26M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -1.88%
- Gross Profit Margin TTM
- 100.83%
- Debt To Equity
- 8.97x
- P/S TTM
- 2.65x
- P/B TTM
- 27.21
- Market Cap
- $367.26M
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is NRC HEALTH in?
NRC HEALTH (NRC) operates in the Services-Commercial Physical & Biological Research industry.
What is NRC's market cap?
NRC HEALTH (NRC) has a market capitalization of $367.26M as of 2026-03-31.
What is NRC's P/E ratio?
NRC HEALTH (NRC)'s trailing twelve month P/E ratio is 40.65x as of 2026-03-31.
What exchange does NRC trade on?
NRC HEALTH (NRC) trades on the NRC: Nasdaq.
Where is NRC HEALTH incorporated?
NRC HEALTH is incorporated in DE.